-
Cy5 maleimide (non-sulfonated): Practical Guide
2026-09-12
Cy5 maleimide (non-sulfonated) is a mono-reactive fluorescent reagent for labeling accessible thiol groups, especially cysteine residues, on peptides and proteins. It is appropriate for controlled conjugation and fluorescence detection but requires an organic co-solvent because of its low aqueous solubility and is not a suitable choice when aqueous-only reagent handling or non-thiol labeling is required.
-
Mouse Tissue Lysis Kit K1038: Workflow Guide
2026-09-12
The Mouse Tissue Lysis Kit K1038 supports rapid digestion of mouse tail, toe, and ear tissue for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and assay development, not diagnostic, clinical, or medical testing.
-
ML365: TASK1 Workflows and Research Applications
2026-09-11
ML365 combines nanomolar TASK1 inhibition with a practical path from ion-channel assays to neuroinflammation studies. Its orthogonal assay performance, channel selectivity, and reported activity in an aged-mouse postoperative model make it useful for target validation, while mGluR5 activity and platform-dependent potency require disciplined controls.
-
Bortezomib (PS-341): Practical Workflow Guide
2026-09-11
Bortezomib (PS-341) provides reversible 20S proteasome inhibition for controlled cell-based studies of proteasome-regulated cellular processes, viability, and apoptosis. Use the dossier values as model-specific reference points rather than universal doses, and do not transfer the reported xenograft dose directly to new animal or clinical protocols.
-
CMA Decline and Age-Related Skeletal Muscle Myopathy
2026-09-10
This study establishes chaperone-mediated autophagy (CMA) as an active regulator of skeletal muscle homeostasis rather than a passive lysosomal pathway. By combining reporter mice, muscle-specific Lamp2a deletion, proteomics, human muscle analysis, and genetic rescue, the authors connect impaired CMA to SERCA turnover, calcium dysregulation, and progressive myopathy.
-
Diuron Workflows for Plant and Toxicology Research
2026-09-10
Diuron enables controlled studies of photosynthetic electron transport, herbicide persistence, and emerging renal toxicity. This practical guide connects plant assays with HK-2 cell workflows, emphasizing solvent control, exposure design, and troubleshooting for reproducible mechanistic data.
-
Moxidectin: From Parasite Control to Assay Design
2026-09-09
Moxidectin is a macrocyclic lactone anthelmintic with an emerging role in polyene-based antifungal research. This article translates the 2024 Candida albicans findings into a practical, mechanism-aware framework for assay design while defining the limits of cross-domain interpretation.
-
Calpain Inhibitor I, ALLN: Practical Protocol Guide
2026-09-09
Calpain Inhibitor I, ALLN (SKU A2602) is a research reagent for experimentally modulating calpain I, calpain II, cathepsin B, and cathepsin L activity in apoptosis, inflammation, and ischemia-reperfusion workflows. It should be used as a mechanistic perturbation tool with appropriate vehicle, protease, and viability controls, not as a diagnostic, clinical, or calpain-exclusive reagent.
-
Exogenous NADH Enhances Aminoglycosides Against E. tarda
2026-09-08
The 2024 study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism and strengthen neomycin-mediated bacterial killing, with ATP-linked energy metabolism emerging as a central feature. Its broader testing across antibiotic classes and resistant pathogens supports metabolic sensitization as a complementary strategy, although translation beyond the tested models remains to be established.
-
Glioblastoma Apoptotic Priming and BH3-Mimetic Therapy
2026-09-07
Koessinger and colleagues show that glioblastoma, including patient-derived stem-like cells, is unusually dependent on anti-apoptotic BCL-XL and MCL-1 for survival. The study links this apoptotic priming to therapeutic sensitivity and demonstrates that sequential inhibition of these proteins can produce strong preclinical antitumor responses.
-
Protein A/G Magnetic Co-IP/IP Kit: From Binding to Biology
2026-09-07
The Protein A/G Magnetic Co-IP/IP Kit connects Fc-directed capture chemistry with rigorous protein-protein interaction analysis. This guide uses the PML–HIF1AN–HIF1α–SOD3 osteogenic differentiation study to show how controls, elution choices, and orthogonal validation convert a Co-IP signal into a defensible biological conclusion.
-
Monomethyl auristatin E (MMAE) Workflow Guide
2026-09-05
A practical guide to using Monomethyl auristatin E as a free-drug control and antibody-drug conjugate payload in cytotoxicity, mechanism, and tumor-cell-state studies. It connects robust assay design with the EBV-associated plasticity findings reported in nasopharyngeal carcinoma while separating established evidence from translational hypotheses.
-
PreScission Protease: HRV 3C Tag Cleavage
2026-09-05
PreScission Protease is a recombinant HRV 3C protease fusion enzyme for sequence-specific fusion-tag removal. Its defined Gln–Gly cleavage site and 4 °C operating condition support recovery of recombinant proteins under cold purification workflows.
-
Dhcr7 Knockout Grass Carp Resists GCRV
2026-09-04
A 2026 Aquaculture Reports study used CRISPR/Cas9 to identify Dhcr7, a cholesterol-biosynthesis enzyme, as an in vivo target for improving grass carp resistance to lethal GCRV-II infection. Dhcr7-disrupted fish showed higher survival, stronger Irf3-associated antiviral responses, lower viral burden, and reduced hepatopancreas injury without detectable effects on measured growth or muscle morphology.
-
Z-IETD-FMK: Caspase-8 Workflow Guide
2026-09-04
Z-IETD-FMK enables pathway-resolved studies of activated T cells, death-receptor signaling, and TRAIL responses without treating mitochondrial caspase activity as a surrogate for caspase-8 activation. This guide combines practical dosing, assay controls, solubility handling, and lessons from an ovarian cancer muscle-atrophy study.